Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases [0.03%]
遗传性前列腺癌中 cribiform 和 intraductal 癌的临床及病理分析(20例报告)
Yuhao Zhang,Yutao Zhang,Minjing Shi et al.
Yuhao Zhang et al.
Cribiform and intraductal carcinoma are patterns of aggressive prostate carcinoma. This study investigated the clinical and pathological features of hereditary prostate cancer. Twenty cases of hereditary prostate cancer from 11 family lines...
Trends in experimental autoimmune prostatitis: insights into pathogenesis, therapeutic strategies, and redefinition [0.03%]
实验性自身免疫前列腺炎研究趋势：对发病机制、治疗策略及重新定义的见解
Robbie Sj Manuel,Chad M Vezina
Robbie Sj Manuel
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPSS) is a debilitating condition characterized by prostate inflammation, pain and urinary symptoms. The immune system's response to self-antigens is a contributing factor to CP/CPSS. In ...
Primary ureteral adenocarcinoma in a patient with previous gastric adenocarcinoma: a rare nonmetastatic case [0.03%]
一位以前患胃腺癌的患者出现主要尿路腺癌的一个罕见非转移性病例
Reza Kazemi,Faezeh Jandaghi,Farzaneh Montazeri
Reza Kazemi
Upper urinary tract adenocarcinoma is a rare malignancy with a challenging diagnosis and limited treatment options. This paper presents a rare case of primary ureteral adenocarcinoma, an exceptionally uncommon malignancy typically associate...
Song Li,Zhenhua Zhao,Jianhua Zhang et al.
Song Li et al.
This study aims to outline the clinical and pathological characteristics of bladder xanthoma, alongside its diagnostic and treatment approaches. Methods: ...
Review of efficacy and safety of same-day discharge after percutaneous nephrolithotomy [0.03%]
经皮肾镜取石术后当日出院的疗效和安全性回顾性分析
Kyra Gassmann,Kavita Gupta,Raymond Khargi et al.
Kyra Gassmann et al.
Purpose: Prior literature reviews have assessed the efficacy and safety of outpatient percutaneous nephrolithotomy (PCNL) with "outpatient" defined as discharge within twenty-four hours of surgery. To our knowledge, this ...
Acute liver injury and contralateral pleural effusion as two rare complications following percutaneous nephrolithotomy: a case report [0.03%]
经皮肾镜碎石术后急性肝损伤和对侧胸腔积液两种罕见并发症的病例报告
Reza Kazemi,Faezeh Jandaghi,Farzaneh Montazeri et al.
Reza Kazemi et al.
Introduction: Percutaneous Nephrolithotomy (PCNL) is a widely used surgical intervention for removing large and complex renal calculi. While considered a safe and effective procedure, it can still lead to severe and rare ...
Follow-up and histocompatibility observation of urethral reconstruction with different materials [0.03%]
不同材料尿道重建术的随访及组织相容性观察
Hongtian Sun,Haoxuan Yang,Mingxuan Yang et al.
Hongtian Sun et al.
Objective: Our objective is to observe the long-term surgical results of urethral reconstruction using either pedicled penile flaps or lingual mucosa grafts. We also assess the histocompatibility of the reconstructed uret...
Prediction of Fuhrman pathological grade of renal clear cell carcinoma based on CT texture analysis [0.03%]
基于CT纹理分析预测肾透明细胞癌的Fuhrman病理分级
Zhuang Dong,Chao Guan,Xuezhen Yang
Zhuang Dong
Objective: To study the predictive performance of the imaging model based on the texture analysis of CT plain scan in distinguishing between low (grade I and II) and high (grade III and IV) of Fuhrman pathological grade o...
Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review [0.03%]
高危前列腺癌根治术前的新辅助化疗内分泌治疗：综述型文章
Junjie Fan,Zhangdong Jiang,Guojing Wang et al.
Junjie Fan et al.
High-risk localized prostate cancer (PCa) has the potential of recurrence and progression to a lethal phenotype, and neoadjuvant therapy followed by radical prostatectomy (RP) may be an option for these patients. Docetaxel has been recently...
Aberrant expression of multiple glycolytic enzyme genes is significantly associated with disease progression and survival outcomes in prostate cancers [0.03%]
前列腺癌中多个糖酵解酶基因的异常表达与疾病的进展及生存结果显著相关
Haixia Xu,Wang Liu,Chenchen He et al.
Haixia Xu et al.
Prostate cancer is the leading cause of cancer death after lung cancer in men. Recent studies showed that aberrant metabolic pathways are involved in prostate cancer development and progression. In this study, we performed a systemic analys...